MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited)
Update 07/07/2026: This Class 4 Medicines Defect Notification has been updated since its initial publication on 30 June 2026 to correct the expiry date for Gabapentin Relonchem 50 mg/ml Oral Solution, batch 21F1. Relonchem Limited has advised that the expiry date previously provided for batch 21F1 was incorrect. The correct expiry date is 01/04/2027. All [...]
The post MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited) appeared first on Community Pharmacy England.
Recent Comments